Status:
COMPLETED
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
Lead Sponsor:
Kyle A Perry
Conditions:
Nausea and Vomiting Post-foregut Surgery
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The effect a ReletexTM device has on postoperative nausea and vomiting when used with ondansetron after foregut surgery will be studied. A ReletexTM device is a FDA approved wristwatch-like device tha...
Eligibility Criteria
Inclusion
- Age 18-85
- Planned fundoplication
- Willingness to comply with randomization and follow-up protocol
- English speaking
Exclusion
- \< 18 years of age or \> 85
- Chronic nausea requiring medical treatment
- Planned concomitant procedures
- Pacemaker or automatic internal cardiac defibrillator
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01510379
Start Date
August 1 2011
End Date
August 1 2012
Last Update
March 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University Medical Center
Columbus, Ohio, United States, 43210